Tuesday - May 6, 2025

LOGIN  |  REGISTER
Cue Biopharma
Assertio

Power of Amwell Hybrid Care Solutions to be Highlighted at HIMSS 2024

March 06, 2024 | Last Trade: US$7.31 0.10 -1.35

Boston, March 06, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, is attending HIMSS 2024, March 11-15, in Orlando, Fla. Company leaders will be in booth #1441 to discuss Amwell’s hybrid care enablement platform, Virtual Nursing solution, automated care and behavioral health programs and how this technology can address workforce shortages, access to care, the mental health crisis and other industry challenges. 

In addition, three Amwell clients will present during two sessions at HIMSS: 

Tuesday, March 12 

  • 10:30 a.m. EST, Room W204A: Tightly Integrating Telehealth for Better Access – Michael Ross, M.D., FAAP, FACMI, vice president and chief medical information officer of Optum Insight, supporting Northern Light Health, will discuss the benefits of a tightly integrated approach to virtual care for large health systems. Northern Light Health uses the Amwell ConvergeTM platform, integrated with its electronic health record, as well as Amwell hardware devices, to support a variety of programs designed to improve patient and provider experiences.  

Wednesday, March 13 

  • 8:30 a.m. EST, Room W207C: Taking a Next-Level Approach to Automated Care: Lessons From Leaders – El Camino Health Chief Information Officer Deb Muro, BSN, MBA, CHCIO, will join Northwell Health’s Clinical Informatics Consultant Kathleen Mazza, Ph.D., RN, MBA, and Associate Chief Medical Officer Zenobia Brown, MD, MPH, in discussing how each health system uses automated care approaches to improve patient outcomes. El Camino Health and Northwell Health use Amwell Automated Care Programs to provide chat-based virtual companions for post-discharge, pre- and post-surgery, chronic conditions, obstetrics and more. 

For more information about Amwell at HIMSS, or to talk with a company leader during the event, contact press@amwell.com
  
About Amwell

Amwell provides a leading hybrid care enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that hybrid care delivery will transform healthcare. The company offers a single, comprehensive platform to support all digital health needs, from urgent to acute and post-acute care, as well as chronic care management and healthy living. With nearly two decades of experience, Amwell powers the digital care of more than 50 health plans, which collectively represent more than 100 million covered lives and many of the nation’s largest health systems. For more information, please visit https://business.amwell.com/.   
   
©2024 American Well Corporation. All rights reserved. Amwell®, SilverCloud®, ConvergeTM, CarepointTM and the Amwell Logo are registered trademarks or trademarks of American Well Corporation.   

Recursion

Stock Quote

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

Featured Stock

Amneal Pharmaceuticals

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page